Association between HLA class II antigens and primary antiphospholipid syndrome from the South of Spain

Abstract

Recent studies have suggested an association between primary antiphospholipid syndrome (PAPS), antiphospholipid antibodies and some major histocompatibility complex (MHC) antigens. We have studied the relationship between MHC class II antigens and PAPS in 19 patients from the south of Spain. Univariant analysis showed an association between PAPS and HLA-DQ7 (47% vs 25%1 P = 0.03), DR4 (32% vs 16%; P = 0.08) and DQ3 (63% vs 39%; P = 0.04). However, multivariant analysis confirmed the association with DQ7 (RR = 2.5; CI 80%:1.3-4.7) and DR4 (RR = 2.2; CI 80%:1.1-4.4) but not with DQ3. When we introduced DRw53 into this analysis, we noticed a DR4 confounding effect, with DQ7 (RR = 3.1; CI 80%: 1.7-5.8) and Drw53 (RR = 2.3; CI 80%: 1.2-4.4) remaining as the most important HLA antigens related to PAPS. In conclusion, in PAPS patients from the South of Spain, HLA-DQ7 antigen showed the highest relative risk for PAPS, followed by DRw53.

Keywords

HLA class II antigens PAPS S. Spain

Get full access to this article

View all access options for this article.

References

Asherson RA , Khamashta MA , Ordi-Ros J. et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Balt) 1989; 68: 366-74.

Asherson RA A primary antiphospholipid syndrome. J Rheumatol 1988; 15: 1742-6.

Vivancos J. , Lopez-Soto A. , Font J. et al. Sindrome anifosfolipido primario: estudio clinico y biologico de 36 casos. Med Clin (Barc) 1994; 102: 561-5.

Savi M. Ferraccioli GF , Neri TM et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988; 31: 1568-70.

Trabace S. , Nicotra M. , Cappellaci S. et al. HLA-DR and DQ antigens and anticardiolipin antibodies in women with recurrent spontaneous abortions. Am J Reprod Immunol 1991; 26: 147-9.

Hartung K. , Coldewey R. , Corvetta A. et al. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus: results of a multicenter study. Autoimmunity 1992; 13: 95-9.

Dagenais P. , Urowitz MB , Gladman DD , Norman CS A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992; 19: 1393-6.

McHugh NJ , Maddison PJ HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1623-4.

McNeil HP , Gavaghan TP , Krilis SA , Geczy AF , Chesterman CN HLA-DR antigens and anticardiolipin antibodies. Clin Exp Rheumatol 1990; 8: 425-7.

10.

May KP , West SB , Moulds J. , Kotzin BL Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 528-33.

11.

Galleazzi M. , Sebastiani GD , Passiu G. et al. Anticardiolipin antibodies and anti-endothelial cell antibodies may share a common genetic background in SLE. Lupus 1992; 1 (Suppl. 1): 33.

12.

Arnett FC , Olsen ML , Anderson KL , Reveille JD Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991; 87: 1490-5.

13.

Reveille JD The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 1992; 4: 644-56.

14.

Gulko PS , Reveille JD , Koopman WJ , Burgard SL , Barolucci AA , Alarcon GS Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations and impact on survival. Arthritis Rheum 1993; 20: 1684-93.

15.

Asherson RA , Doherty DG , Vergani D. , Khamashta MA , Hughes Grv. Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992; 35: 1124-5.

16.

Goldstein B. , Smith CD , Sengar Dps. MHC class II studies of primary antiphospholipid antibody syndrome and of serum antiphospholipid antibodies in systemic lupus erythematosus. Arthritis Rheum 1990; 33: S125.

17.

Harris EN Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-6.

18.

Hughes Grv. The antiphospholipid syndrome: ten years on . Lancet 1994; 342: 341-4.

19.

McCarty GA , Valencia DW , Fritzler MJ Antinuclear Antibodies. Contemporary Techniques and Clinical Application to Connective Tissue Disease. Oxford University Press: Oxford, 1984.

20.

Aarden LA , Degroot ER , Feltkamp Twe. Immunology of DNA. III. Cruthidia lucilliae: a simple substrate for the detection of anti-dsDNA with immunofluorescence technique. Ann NY Acad Sci 1975; 254: 505-15.

21.

Ouchterlony O. , Nilsson LA Immunodiffusion and immunoelectrophoresis . In: Handbook of Experimental Immunology, vol. 1. Immunochemistry. Weir DM (ed.). Oxford: Blackwell Scientific Publications, 1986: 32.1-32.5.

22.

Exner T. , Richard KA , Kronemberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural pattern . Br J Haematol 1978; 54: 709-12.

23.

Loizou S. , McCrea JD , Rudge AC , Reynolds R. , Boyle CC , Harris EN Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-45.

24.

Harris EN The second international anticardiolipin antibody standardization workshop/the Kingston antiphospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476-81.

25.

Camps Garcia MT , Gutierrez Rueda A. , Guil Garcia M. et al. Anticuerpos anticardiolipina en mujeres con abortos de repeticion. Estudio de casos y controles. Ann Med Intern (Madrid) 1992; 9: 585-90.

26.

Terasaki PI Microdroplet assay for human blood lymphotoxins. In: Histocompatibility Testing. Washington, DC: National Academy of Science, 1965.

27.

Bodmer JG , Marsh Sge , Abert ED et al. Nomenclature for factors of the HLA system, 1991. Tissue Antigens 1992; 39: 161-73.

28.

Sebastiani GD , Lulli P. , Passiu G. et al. Anticardiolipin antibodies: their relationship with HLA-DR antigens in systemic lupus erythematosus. Br J Rheumatol 1991; 30: 156-7.

29.

Gomez-Reino JJ , Martinez-Laso J. , Vicario JL et al. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers. Immunobiology 1991; 182: 465-71.

30.

Fronek Z. , Timmerman LA , Alper CA et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus. Arthritis Rheum 1990; 33: 1542-53.

31.

Camps Garcia MT , Ocon Sanchez P. , Alonso Ortiz A. et al. Antigenos HLA de clase I y II en pacientes con lupus eritematoso sistematico en el sur de Espana. Med Clin (Barc) 1994; 102: 12-17.

32.

Out HJ , van Vliet M. , Groot P. , Derksen Rhwm. Prospective study of fluctuation of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 353-7.